Levofloxacin Market Competitive Landscape, Trends, Growth Factors, Revenue Analysis with Top Key Players

IndustryARC

Market Research Reports, Business Consulting Services & Analytics

A rising number of hospitals and retail pharmacies are set to aid the growth of the levofloxacin market

HYDERABAD, TELANGANA, INDIA, January 12, 2023 /EINPresswire.com/ -- Levofloxacin Market is forecast to reach $1.9 Billion by 2025, growing at a CAGR of 4.7% during the forecast period 2020-2025. Levofloxacin is an antibiotic marketed under the brand name Levaquin used for the destruction of bacteria inside the body. The mechanism of levofloxacin and other fluoroquinolone antimicrobials involves the inhibition of bacterial topoisomerase IV and DNA gyrase. It is an injectable drug and is also marketed in tablet form. This drug is used for the diagnosis of pneumonia, acute bacterial sinusitis, chronic prostatitis, urinary tract infection and others. It is indicated for inhalational anthrax (post-exposure) to reduce the incidence or progression of disease exposure to aerosolized Bacillus anthracis. Budesonide and fluticasone are the replacement for the levofloxacin drug.

Click here to browse the complete report summary:
https://www.industryarc.com/Research/Levofloxacin-Market-Research-501909

Key Takeaways

Rising government initiatives with the objective of improving awareness about the diagnosis and treatment of pneumonia and similar infections is expected to aid the growth of the market.

A rising number of hospitals and retail pharmacies are set to aid the growth of the levofloxacin market.

APAC region is estimated to record the fastest growth rate during the forecast period 2020-2025

Interested in knowing more relevant information? Click here:
https://www.industryarc.com/pdfdownload.php?id=501909

Segment Analysis

1. The Skin Infection segment dominated the Levofloxacin market in terms of revenue. The segment is estimated to grow at a CAGR of 2.8%. Levofloxacin is mostly used in skin infections as it is indicated for the treatment of complicated skin and skin structure infections due to methicillin-susceptible Staphylococcus aureus, Enterococcus faecalis, Streptococcus pyogenes, or Proteus mirabilis and others. Skin infections include abscesses, cellulitis, furuncles, impetigo, pyoderma, wound infections and others.

2. The Hospital Pharmacy segment dominated the Levofloxacin market in terms of revenue. As hospital pharmacies hold stock of a larger range of medications, including more specialized and investigational medications. It contains all the forms of dosage and guides in the proper usage of levofloxacin.

3. Based on geography the Levofloxacin market is covered globally viz North America, South America, Europe, Asia Pacific (APAC) and the Rest of World (ROW). The market in North America accounts for a major share of 44% in terms of revenue and is projected to maintain its position over the forecast period 2020-2025. Rising number of government initiatives with the objective of improving awareness about the diagnosis. Asia Pacific market is estimated to register the highest CAGR in terms of revenue over the forecast period 2020-2025, owing to the major expansion in manufacturing pharmacies.

Competitive Landscape:

The top 5 players in the Levofloxacin Industry are -

1. Aden Healthcare
2. Allenge India Pharma
3. Alna Biotech Private Limited
4. Bestochem
5. Divine Savior Healthcare

Click on the following link to buy the Levofloxacin Market Report:
https://www.industryarc.com/reports/request-quote?id=501909

Why Choose IndustryARC?

IndustryARC is one of the leading market research and consulting firms in the world. It produces over 500 unique market reports annually. If you are looking for a detailed overview of a particular market, you can simply connect with the team at IndustryARC. You can not only buy your preferred market report from the website but also get personalized assistance on specific reports.

Contact Us:

Mr Venkat Reddy
IndustryARC
Email: venkat@industryarc.com, sales@industryarc.com
USA: (+1) 970-236-3677, (+1) 815-656-4596
IND: (+91) 40-485-49062

Venkat Reddy
IndustryARC
+1 614-588-8538
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.